Healthcare Stocks Cardiol Therapeutics Announces Year-End 2023 Update on Operations Completed patient enrollment in the Phase II MAvERIC-Pilot study evaluating CardiolRx™ in… Ryan AllwayApril 2, 2024
Feature Healthcare Stocks Top News The Impact of Positive Phase 2 Trial Results on a Smaller Company A few weeks back, we covered the effect an Orphan Drug Designation… Robin LeffertsMarch 12, 2024
Feature Healthcare Stocks Top News Distinguished Health Centers and Experts Lead Recurrent Pericarditis, Acute Myocarditis Clinical Trials Any clinical trial program relies heavily on its administrators, advisors, and designers.… Robin LeffertsJanuary 16, 2024
